Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $43.3850 (1.95%) ($43.3850 - $43.6700) on Wed. Apr. 20, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.06% (three month average) | RSI | 71 | Latest Price | $43.3850(1.95%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.8% a day on average for past five trading days. | Weekly Trend | HALO advances 1.5% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(49%) IWM(44%) IWO(44%) IWN(42%) IWC(41%) | Factors Impacting HALO price | HALO will decline at least -1.03% in a week (0% probabilities). VIXM(-23%) UUP(-10%) VXX(-8%) TBT(-4%) GLD(1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.03% (StdDev 2.06%) | Hourly BBV | 1.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $42.26(2.66%) | 10 Day Moving Average | $42.07(3.13%) | 20 Day Moving Average | $41.04(5.71%) | To recent high | 0% | To recent low | 35.7% | Market Cap | $5.93b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |